Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Dec 5, 2025, 4:00 PM EST - Market closed
Skye Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -51.23 | -26.57 | -37.64 | -19.48 | -8.52 | -6.56 | Upgrade
|
| Depreciation & Amortization | 0.72 | 0.3 | 0.12 | 0.11 | 0.03 | 0 | Upgrade
|
| Other Amortization | - | 0.6 | 0.33 | 0.49 | 0.59 | 0.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.32 | -1.35 | 0.3 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 21.22 | - | - | - | Upgrade
|
| Stock-Based Compensation | 8.24 | 8.32 | 0.99 | 0.63 | 0.87 | 0.3 | Upgrade
|
| Other Operating Activities | 0.32 | -3.91 | 1.2 | 6.27 | -0.1 | -0.44 | Upgrade
|
| Change in Accounts Payable | 1.98 | -0.59 | -0.7 | 0.8 | 0.52 | 0.24 | Upgrade
|
| Change in Other Net Operating Assets | -1.17 | -2.04 | 0.23 | -1.56 | 0.13 | -0.15 | Upgrade
|
| Operating Cash Flow | -41.47 | -25.24 | -13.95 | -12.74 | -6.47 | -6.05 | Upgrade
|
| Capital Expenditures | -0.06 | -1.6 | -0.01 | -0.09 | -0.09 | -0.01 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.32 | 1.36 | 5.53 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | 1.08 | 5.31 | - | - | Upgrade
|
| Investing Cash Flow | -16.61 | -0.25 | 6.6 | 5.21 | -0.09 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | - | 4.97 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.68 | - | 0.57 | Upgrade
|
| Total Debt Issued | - | - | 4.97 | 0.68 | - | 0.57 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.26 | -0.89 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 4.71 | -0.21 | - | 0.57 | Upgrade
|
| Issuance of Common Stock | 6.44 | 90 | 12 | 0 | 14.01 | 6.99 | Upgrade
|
| Other Financing Activities | -6.42 | -6.43 | -0.27 | - | -0.94 | -0.85 | Upgrade
|
| Financing Cash Flow | 0.02 | 83.56 | 16.44 | -0.21 | 13.08 | 6.7 | Upgrade
|
| Net Cash Flow | -58.05 | 58.08 | 9.09 | -7.74 | 6.51 | 0.64 | Upgrade
|
| Free Cash Flow | -41.53 | -26.84 | -13.96 | -12.84 | -6.57 | -6.06 | Upgrade
|
| Free Cash Flow Per Share | -1.04 | -0.74 | -1.99 | -5.78 | -4.04 | -6.55 | Upgrade
|
| Cash Interest Paid | 0.43 | 0.43 | 0.2 | 0.33 | 0.04 | 0.12 | Upgrade
|
| Cash Income Tax Paid | 0.01 | 0.01 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -14.4 | -9.05 | -11.04 | -9.44 | -3.28 | -3.81 | Upgrade
|
| Unlevered Free Cash Flow | -14.4 | -9.18 | -10.8 | -9.51 | -3.39 | -3.91 | Upgrade
|
| Change in Working Capital | 0.81 | -2.63 | -0.47 | -0.76 | 0.65 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.